Clinical Trials Browser

Phase 1/2 × Unknown × Vinorelbine × Clear all

NCT00764972 2008-10-21

Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer

Phase 1/2 Unknown

Breast Neoplasms